Skip to main content
. Author manuscript; available in PMC: 2017 Mar 28.
Published in final edited form as: Cancer Lett. 2016 Jan 18;372(2):179–186. doi: 10.1016/j.canlet.2016.01.018

Fig. 6.

Fig. 6

Effect of entrectinib in combination with Irino-TMZ on SY5Y-TrkB xenograft growth. A. Growth pattern of SY5Y-TrkB xenografts. Significant inhibition of tumor growth was observed in the entrectinib (single agent or combination with Irino-TMZ) compared to control or Irino-TMZ group. B. Kaplan-Meier survival curves of SY5Y-TrkB xenografts. Statistically significant differences in EFS were observed in the combination treated groups compared to Irino-TMZ alone.